bioAffinity Technologies (BIAF) Debt Ratio (2021 - 2026)

bioAffinity Technologies has disclosed Debt Ratio across 6 years of filings, most recently posting 0.0 for Q1 2026.

• In Q1 2026, Debt Ratio fell 43.58% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 43.58% YoY), while the FY2025 annual figure was 0.0, up 21.66% from the prior year.
• Debt Ratio advanced to 0.0 in Q1 2026, from 0.0 in the prior quarter.
• Over the last five years, Debt Ratio for BIAF reached as high as 0.04 in Q3 2022 and fell as low as 0.0 in Q1 2024.
• The 5-year median for Debt Ratio is 0.0 (2023), against an average of 0.01.
• Annual changes were most pronounced in 2022 — Debt Ratio sank 85.85% — and 2025, when it soared 203.32%.
• A 5-year view of Debt Ratio shows it stood at 0.02 in 2022, then plunged by 76.91% to 0.0 in 2023, then tumbled by 35.06% to 0.0 in 2024, then climbed by 21.66% to 0.0 in 2025, then climbed by 29.95% to 0.0 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.